Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?

Short Seller Behind Globe Life’s 53% Plunge Has Winning Record

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Optimistic Buy Rating for Collegium Pharmaceutical: Growth and Market Position Analysis

Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know

Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

Humana (HUM), DUOS Unveil Program to Improve Veterans' Health

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

Time to Get These 5 Top Relative Price Strength Stocks

3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock

3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock

Encompass Health (EHC), Piedmont to Build Loganville Facility